Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remazolam for Anesthesia Recovery in Fundus Surgery
NCT06205719Phase 1Not yet recruiting
- Sponsor
- Sichuan Provincial People's Hospital
- Start
- Jun 2024
- Primary completion
- May 2025
- Modality
- Small Molecules
01
Overview
Phase 1, randomised, double-blind trial of remimazolam mesylate in Anesthesia (3 arms), sponsored by Sichuan Provincial People's Hospital. Primary endpoint: Time for recovery. Planned start Jun 2024; status: not yet recruiting.
02
Drugs
remimazolam mesylate
03
Conditions
Anesthesia
Beyond the preview
Go deeper on NCT06205719.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06205719.